The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu

The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu Based on Non-invasive PCR in Stool

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05654857

Enrollment

4000

Registered

2022-12-16

Start date

2023-03-01

Completion date

2023-08-30

Last updated

2023-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter Pylori Infection

Keywords

Resistance Mutation, Fecal Drug Resistance Gene Detection

Brief summary

To assess Family-unit Helicobacter Pylori Infection rates and antimicrobial resistance rates in Jiangsu,China

Detailed description

The study is a sample survey of the community population in cities of Jiangsu where the centers are located.The Helicobacter pylori infection and drug-resistant gene mutations are detected by real-time PCR performed on the stools of subjects.

Interventions

DIAGNOSTIC_TESTPCR test in the stool

Patients will receive a prescription for a stool self-collection kit . Only the result of the PCR test in the stool will be considered for this arm. A positive test will determine Hp infection and the indication for treatment.

Study design

Observational model

CASE_ONLY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

6 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

1. community population 2. Fecal samples can be obtained, and the sample volume meets the requirements of the collection tube instructions 3. Only one person per family can be selected 4. Voluntarily participated in this study and signed an informed consent form

Exclusion criteria

1. The collector does not cooperate or has poor compliance; 2. Adequate and qualified fecal samples could not be obtained; 3. Stool samples were collected during diarrhea or constipation; 4. Antibiotics, bismuth preparations, proton pump inhibitors and other Hp sensitive drugs have been used within one month.

Design outcomes

Primary

Measure	Time frame	Description
The Prevalence of Family-unit Helicobacter Pylori Infection in Jiangsu	2022.12.1-2023.6.30	the Helicobacter Pylori Infection rate in Jiangsu family

Secondary

Measure	Time frame	Description
Trends of Antimicrobial Resistance of Helicobacter Pylori in Jiangsu	2022.12.1-2023.6.30	resistance to antimicrobial agents applicable for H. pylori eradication

Countries

China

Contacts

Primary ContactZhenyu Zhang

zzy6565@sina.com+86 025-87726248

Backup ContactYunfan Dong

dyf967878@163.com+86 18795993220

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026